lab-asset-in-pharma.com Open in urlscan Pro
5.134.13.35  Public Scan

Submitted URL: https://info.hansonwade.com/e/448062/y-expanded-cafm-em-02-ev-25908/9z3tfc/1166405020?h=ydL2-y4CgBVh2hnfZMjf2X4b9OVwyAKUhhW9...
Effective URL: https://lab-asset-in-pharma.com/?utm_source=internal&utm_medium=email&utm_campaign=relaunch&utm_content=primary-expanded/cafm/em...
Submission: On June 17 via api from DE — Scanned from DE

Form analysis 1 forms found in the DOM

GET https://lab-asset-in-pharma.com/

<form role="search" method="get" id="searchform" class="searchform" action="https://lab-asset-in-pharma.com/">
  <div>
    <label class="screen-reader-text" for="s"> Search</label>
    <input type="text" value="" name="s" id="s" placeholder="">
    <input type="submit" id="searchsubmit" value="Search">
  </div>
</form>

Text Content

Skip to content


NOVEMBER 1-3, 2022 |
BOSTON, MA

Menu

 * Home
 * About
   * About Event
   * Venue & Accommodation
   * Testimonials
   * Content Library
 * Program
   * Full Event Guide
   * 2022 Speakers
   * 101 Bootcamp
   * Optimization Workshops
   * Agenda
     * Conference Day One
     * Conference Day Two
 * Partnerships
   * Partnership Opportunities
   * 2022 Partners
 * Get Involved
   * Pricing & Register
   * Requesting Budget
   * Contact us




NOVEMBER 1-3, 2022 |
BOSTON, MA

Menu

 * Home
 * About
   * About Event
   * Venue & Accommodation
   * Testimonials
   * Content Library
 * Program
   * Full Event Guide
   * 2022 Speakers
   * 101 Bootcamp
   * Optimization Workshops
   * Agenda
     * Conference Day One
     * Conference Day Two
 * Partnerships
   * Partnership Opportunities
   * 2022 Partners
 * Get Involved
   * Pricing & Register
   * Requesting Budget
   * Contact us




ENSURING R&D SUCCESS THROUGH TRANSFORMATIVE LAB OPERATIONS

Implement Next Generation Asset Management, Facility Design, Supply Chain &
Sustainability, to Free Up Capital for Reinvestment & Provide a
Lab Environment Primed for Innovation




NOVEMBER 1-3, 2022 | BOSTON, MA

FULL EVENT GUIDE
REGISTER
PARTNER


WELCOME TO THE 5TH ANNUAL LAB ASSET & FACILITY MANAGEMENT IN PHARMA 2022

Pharma R&D return on investment has risen to its highest levels since 2014,
there’s never been a more impactful time to translate savings in capital spend
into results for patients in need. The 5th LAFM Summit will return to unite lab
operations, asset and facility managers in their quest to support stakeholders,
manage reactive business continuity whilst providing a platform for sustainable
& ambitious organizational growth.

As the only peer led community for R&D operations leaders, from large pharma to
start-ups, meet your new network this November and level up your career in lab
operations, facility and asset management.

New for 2022 the 5th LAFM summit will host three tracks of content to dive down
into asset management and maintenance in large pharma, facility design in
expanding organizations, and end-to-end operations in early-stage biotech.

Leverage next generation technologies, overcome supply chain challenges and find
inspiration to make a real impact in your organization, no matter your headcount
or resources.




VIEW THE FULL EVENT GUIDE NOW!

Download your copy to see all the 2022 speakers, full agenda breakdown, partners
and how you can access the best possible rates.

FULL EVENT GUIDE


40+ EXPERT INDUSTRY SPEAKERS:


LARGE PHARMA

CHARLES BRUSEO

Director, Research Strategy & Operations

Bristol Myers Squibb



JD FIER

Head of MA Bio Ops Reliability Engineering

Takeda Pharmaceutical Co. Ltd.



JESSIE DOW

Lab Operations Lead

Pfizer



JILL DEGREEN

Senior Manager - Operations

Novo Nordisk



MARLOES MILLER

Associate Director, R&D Lab Operations

AstraZeneca



PARTHA KRISHNAN

Deputy Director - Health, Safety & Environment

Sanofi



RICHARD SNELL

Scientific Services Director

GSK



TED SCHILLING

Global Director of Engineering Services

Seagen





EXCITING BIOTECH

AMANDA ALLEN

Executive Director, Facilities & Operations

Odyssey Therapeutics



MATTHEW O’BRIEN

Senior Director of Scientific Operations

Treeline Biosciences



MIKHAEL DANAN

Director R&D, Clinical IT

Affinivax



SANDY MORALES

Director, Facilities & EH&S

Concert Pharmaceuticals





CONFERENCE CHAIRS

KIM DOUGHERTY

Director, Laboratory Operations

Atalanta Therapeutics



STEVEN DRIVER

Principal Engineer and Energy Program Mananger

Sanofi



VIEW ALL SPEAKERS



WHAT’S NEW FOR 2022?


REFOCUSED: ASSET MANAGEMENT TRACK

The AM track hones in on the cutting edge asset management programs at large
pharma, uncovering next generation asset monitoring, utilization, maintenance
and reliability innovations across the full asset lifecycle


REFOCUSED: FACILITY DESIGN & DIGITAL FACILITIES TRACK

With space as the hottest commodity in biopharma, this track highlights the most
recent facility designs to maximize space and workflow efficiency,
sustainability and digital tools




NEW: EARLY-STAGE BIOTECH TRACK

This brand-new track for 2022 covers a comprehensive view of lab operations in
start-up & SME biotech, the flexible and adaptable solutions to working in a
fastgrowing company, and the many hats a lab operations professional has to
juggle in the start up and SME biotech world!




LEAD PARTNER




EXPERTISE PARTNERS





PROGRAM, INNOVATION & EXHIBITION PARTNERS



PARTNER

REGISTER
FULL EVENT GUIDE
SPEAKERS


OUR CONTACT DETAILS

T: +1 617 455 4188
E: info@hansonwade.com


ABOUT US

Hanson Wade's goal is to accelerate progress within organisations and across
industries. Our primary method for achieving this is by creating exclusive
business conferences that gather together the world's smartest thinkers and
doers.


LOCATION

Westin Boston Seaport District
425 Summer St,
Boston, MA.
02210




SEARCH

Search


ORGANISED BY



Terms & Conditions

Privacy Policy




© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade
Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.

We use cookies to ensure that we give you the best experience on our website. If
you continue to use this site we will assume that you are happy with it.Ok